Address And Details

82 Devonshire St , Boston, MA 02109
Fund Manager Greg Lee
Manager Tenure 9 Years 10 Months

Strategy And Objective

The fund seeks capital appreciation. The Adviser normally invests at least 80% of the fund's assets in securities of issuers in emerging markets and other investments that are tied economically to emerging markets. Emerging markets include countries that have an emerging stock market as defined by MSCI, countries or markets with low- to middle-income economies as classified by the World Bank, and other countries or markets with similar emerging characteristics. Emerging markets tend to have relatively low gross national product per capital compared to the world's major economies and may have the potential for rapid economic growth. The Adviser normally invests the fund's assets primarily in common stocks. The Adviser allocates the fund's assets across emerging market sectors, using different Fidelity managers to handle investments. At present, those sectors include consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology, materials, real estate, telecom services, and utilities. The Adviser expects the fund's sector allocations will approximate the sector weightings of the MSCI Emerging Markets SMID Cap Index. While the Adviser may overweight or underweight one or more sectors from time to time, the Adviser expects the returns of the fund to be driven primarily by the security selections of the managers of each sector. The Adviser normally allocates the fund's investments across different emerging market countries. The Adviser is not constrained by any particular investment style. At any given time, the Adviser may tend to buy "growth stocks or "value" stocks, or a combination of both types. In buying and selling securities for the fund, the Adviser relies on fundamental analysis, which involves a bottom-up assessment of a company's potential for success in light of factors including its financial condition, earnings outlook, strategy, management, industry position, and economic and market conditions. If the Adviser's strategies do not work as intended, the fund may not achieve its objective.

Net Asset Value

as of 5:22 PM ET 09/17/2021


  • 1 Week
  • -0.94%
  • 1 Month
  • +2.64%
  • 3 Months
  • -0.31%
  • 1 Yr Return
  • +31.24%
  • 5 Yr Return
  • +57.93%

Equity Sector Breakdown

IndustrialCyclical 20.00%
RetailTrade 13.38%
Finance 12.52%
Technology 7.33%
NonDurables 5.33%
Health 4.37%
Services 3.61%
ConsumerDurables 3.43%
Energy 2.90%
Utilities 1.96%

Asset Allocation

Asset Type % Of Allocation
Stocks 96.28%
ForeignStocks 90.82%
Preferred 1.04%
Cash 0.00%
Bonds 0.00%
Convertible 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 29.20 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -2.18 -3.30 n/a
Beta 0.94 0.88 n/a
R Squared 0.67 0.54 n/a
Std Deviation 21.22 18.01 n/a
Sharpe Ratio 0.71 0.66 n/a

Purchase Information

as of 5:17 PM ET 09/16/2021
Minimum Initial $0
Minimum Additional $0
Minimum Initial IRA $0


Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +34.84%
  • +45.92%
+34.84% +45.92%
3 Year
  • +13.62%
  • +11.70%
+13.62% +11.70%
10 Year
  • n/a
  • n/a
n/a n/a
Life Of Fund
  • +8.38%
  • +8.56%
+8.38% +8.56%

Top 10 Holdings

Symbol Company Name % Of Assets
6415.TW SILERGY CORP 2.27%
035720 KAKAO CORP 1.23%

Recent Articles from TheStreet


As Demand for Corn Grows, New Key Data Points to Watch

What data should corn market watchers seek out in a tight market? A new volatility gauge offers some answers.

Pfizer vaccine Lead

Pfizer Says Its COVID Vaccine Safe For Children 5 to 11 In Lower Doses

"These trial results provide a strong foundation for seeking authorization of our vaccine for children 5 to 11 years old, and we plan to submit them to the FDA and other regulators with urgency," said Pfizer CEO Albert Bourla.

Wall Street NYSE Lead

Dow Futures Slump As China Evergrande, Growth Worries Rattle Global Stocks

The potential collapse of indebted property developer China Evergrande has added to market angst ahead of what could be a crucial meeting of the Federal Reserve later this week.

Wall Street Lead

Stocks Slump, Evergrande Plunges, Canadians Vote, Ted Lasso Charms - 5 Things You Must Know

Stock futures slump on China, growth risk; China Evergrande plunges as bond payments loom; FDA panel awaits more data on COVID; Canadians got to the polls and Ted Lasso and The Crown sweep top Emmy awards.

Elon Musk Starlink Lead

SpaceX CEO Elon Musk Says Starlink Exits Beta Next Month

SpaceX CEO Elon Musk says the company’s Starlink high-speed internet service will come out of beta testing next month.

Wall Street Lead

Cramer: Using Short-Term Moves to Tweak Your Portfolio

Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.

10. Chemical & petrochemical pharma sh

Jensen: These Three Healthcare Stocks Are Worth a Look

Just because we're in the market's worst month of the year doesn't mean there aren't good investments available.

18. Apple Inc. (AAPL)

Parus Files Second Patent Infringement Lawsuit Against Apple

Parus files a second patent infringement lawsuit against Apple, alleging it infringed on its patents for voice-browsing and device control technology.

12. Software engineer

Business Software Provider AvidXchange Files for IPO

Accounts payable software provider AvidXchange on Friday filed for a initial public offering.

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable